A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Maintainers and developers are now using AI to help build Linux. Simultaneously, Rust has graduated to being a co-equal language with C for mainstream Linux development. However, the programming world ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, ...